Pediatr. praxi. 2011;12(1):36-38

Secondary cerebellar glioblastoma in a child previously treated for medulloblastoma

doc.MUDr.Eva Brichtová, Ph.D.
Neurochirurgické oddělení, Klinika dětské chirurgie, ortopedie a traumatologie FN a LF MU Brno

Medulloblastoma and glioblastoma multiforme are completely different types of brain tumors in the parameters of the patients‘ age

and location of occurrence. Secondary glioblastoma is the most common solid tumor induced by radiotherapy. The prognosis of these

secondary malignancies despite aggressive multimodal therapy is still very bleak. The author presents a case report of sixteen-year-old

boy suffering from posterior cranial fossa secondary glioblastoma 6 years after combined treatment for medulloblastoma in the same

location. Features of clinical manifestations, pathological and cytogenetic findings and treatment options are presented.

Keywords: medulloblastoma, glioblastoma multiforme, radiotherapy, secondary malignancy, radiotherapy induced glioma

Published: February 23, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brichtová E. Secondary cerebellar glioblastoma in a child previously treated for medulloblastoma. Pediatr. praxi. 2011;12(1):36-38.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brada M, Ford D, Ashley S, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br Med J 1992; 304: 1343-1346. Go to original source... Go to PubMed...
    2. Romeike BF, Kim YJ, Steudel WI, Graf N. Diffuse high grade gliomas as second malignant neoplasms after radiochemoterapy for pediatric malignancies. Childs Nerv Syst 2007; 23: 185-193. Go to original source... Go to PubMed...
    3. Peterson KM, Shao CH, McCarter R, et al. An Analysis of SEER Data of Increasing Risk of Secondary Malignant Neoplasm Among Long-Term Survivors of Childhood Brain Tumors. Pediatr Blood Cancer 2006; 47: 83-88. Go to original source... Go to PubMed...
    4. Finlay JL, Goldman S, Wong MC, et al. A pilot study of high dose thiotepa and episode with autologous bone marrow rescue in children and young adults with reccurent central nervous system tumors. J Clin Oncol 1996; 14: 2495-2503. Go to original source... Go to PubMed...
    5. Hodgson DS, Goumnerova LC, Loeffler JS, et al. Radiosurgery in the management of pediatric brain tumors. Int J Rad Oncol Biol Phys 2001; 50: 929-935. Go to original source... Go to PubMed...
    6. Meadows AT, Fenton J. Follow-up care of patients at risk for the development of second malignant neoplasm. In: Schwarz C, et al. Survivors of childhood cancer. St. Louis: Mosby 1994: 319-327.
    7. Cahan WG, Woodard HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone: report of eleven cases. Cancer 1998; 82: 8-34. Go to original source...
    8. Sterba J, Valik D, Mudry P, et al. Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot study. Onkologie 2006; 29(7): 308-313. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.